Trial Details
RECRUITINGBasic Information
| Clinical ID | c4330 |
|---|---|
| Identifier | NCT00692939 |
| Trial Title | Autologous Stem Cell Transplantation for Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: autologous CD34-selected peripheral blood stem cells transplant|DRUG: Alemtuzumab|DRUG: ATG|DRUG: Melphalan|DRUG: Thiotepa|DRUG: Rituximab|DRUG: Cyclophosphamide|DRUG: G-CSF|DRUG: Mesna |
Participant Information
| Sponsor | Paul Szabolcs |
|---|---|
| City | Pittsburgh |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2012-06-26 |
|---|---|
| Primary Completion Date | 2026-12 |
| Completion Date | 2027-12 |